← Back to directory

Yaron Ilan

Researcher Next ID · RN-042270

Researcher · Immunology and Microbiology

Hadassah Medical Center

Jerusalem, Israel

Accepting doctoral researchersFunding unknown
Works count
420
Citation count
10,966
H-index
58
i10-index
240

Research interests

Immunology and Microbiology
Medicine
Liver Disease Diagnosis and Treatment
Immune Cell Function and Interaction
Hepatitis C virus research
Hepatitis B Virus Studies
Liver Disease and Transplantation

Publications

  • Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases

    European Journal of Human Genetics · 2021 · 10.1038/s41431-021-00928-4

  • Microtubules: From understanding their dynamics to using them as potential therapeutic targets

    Journal of Cellular Physiology · 2018 · 10.1002/jcp.27978

  • Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis

    World Journal of Gastroenterology · 2012 · 10.3748/wjg.v18.i21.2609

  • Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice

    Proceedings of the National Academy of Sciences · 2010 · https://doi.org/10.1073/pnas.0908771107

  • Adoptive transfer of regulatory NKT lymphocytes ameliorates non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping

    The Journal of Pathology · 2006 · 10.1002/path.1950

  • Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC

    Journal of Hepatology · 2006 · https://doi.org/10.1016/j.jhep.2005.12.025

  • Treatment of Chronic Hepatitis C Virus Infection via Antioxidants

    Journal of Clinical Gastroenterology · 2005 · 10.1097/01.mcg.0000174023.73472.29

  • Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis

    Journal of Clinical Gastroenterology · 2002 · 10.1097/00004836-200207000-00016

  • Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

    Blood · 2002 · 10.1182/blood.v100.2.391

  • Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat

    Hepatology · 1997 · 10.1002/hep.510260422

  • Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.

    Journal of Clinical Investigation · 1997 · 10.1172/jci119238

  • Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

    Proceedings of the National Academy of Sciences · 1997 · 10.1073/pnas.94.6.2587

  • Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats.

    Journal of Clinical Investigation · 1996 · 10.1172/jci119085

  • Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period

    Journal of Biological Chemistry · 1996 · 10.1074/jbc.271.43.26536

  • Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

    Vaccine · 1994 · 10.1016/0264-410x(94)90155-4

  • Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor

    Gastroenterology · 1993 · 10.1016/0016-5085(93)90664-x

  • Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation

    Hepatology · 1993 · 10.1002/hep.1840180204

Current projects

    No projects listed.